Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity
Diabetes · 2023
DOI: 10.2337/db23-0317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Mulin He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, The State University of New York Downstate Health Sciences University, Brooklyn, NY. Hauptthemen laut MEDLINE: Phosphatidylcholines, Insulin Resistance. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, BLRD VA.
Abstract (Originalsprache)
Cell membrane phosphatidylcholine (PC) composition is regulated by lysophosphatidylcholine acyltransferase (LPCAT); changes in membrane PC saturation are implicated in metabolic disorders. Here, we identified LPCAT3 as the major isoform of LPCAT in adipose tissue and created adipocyte-specific Lpcat3–knockout mice to study adipose tissue lipid metabolism. Transcriptome sequencing and plasma adipokine profiling were used to investigate how LPCAT3 regulates adipose tissue insulin signaling. LPCAT3 deficiency reduced polyunsaturated PCs in adipocyte plasma membranes, increasing insulin sensitivity. LPCAT3 deficiency influenced membrane lipid rafts, which activated insulin receptors and AKT in adipose tissue, and attenuated diet-induced insulin resistance. Conversely, higher LPCAT3 activity in adipose tissue from ob/ob, db/db, and high-fat diet–fed mice reduced insulin signaling. Adding polyunsaturated PCs to mature human or mouse adipocytes in vitro worsened insulin signaling. We suggest that targeting LPCAT3 in adipose tissue to manipulate membrane phospholipid saturation is a new strategy to treat insulin resistance. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, The State University of New York Downstate Health Sciences University, Brooklyn, NY.
- Lipidomics Core, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
- Molecular and Cellular Cardiology Program, Veterans Affairs New York Harbor Healthcare System, New York, NY.
ORCID-Profile: Xianlin Han, Xian-Cheng Jiang
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- BLRD VA
- NIH HHS
- VA
- NIH
Zitieren
APA
He, M., Li, Z., Tung, V. S. K., Pan, M., Han, X., Evgrafov, O., & Jiang, X. C. (2023). Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity. Diabetes. https://doi.org/10.2337/db23-0317
Vancouver
He M, Li Z, Tung VSK, Pan M, Han X, Evgrafov O, et al. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity. Diabetes. 2023. doi:10.2337/db23-0317
BibTeX
@article{He2023,
author = {He, Mulin and Li, Zhiqiang and Tung, Victoria Sook Keng and Pan, Meixia and Han, Xianlin and Evgrafov, Oleg and Jiang, Xian-Cheng},
title = {Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db23-0317}
}
EUVIMED